SAQ Training Versus Small-Sided Games for Cardiovascular Adaptations in Youth Football Players (SAQ-SSG)
Comparative Effects of Speed, Agility, and Quickness Training and Small-Sided Games on Cardiovascular Response in Youth Football Players: A Randomized Controlled Trial
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Football training methods may induce different physiological and cardiovascular adaptations in youth athletes. Speed, Agility, and Quickness (SAQ) training is widely used to enhance neuromuscular performance, while Small-Sided Games (SSGs) provide sport-specific training stimuli that combine technical, tactical, and physical demands.
The purpose of this randomized controlled trial was to compare the effects of SAQ training and SSGs on cardiovascular responses in youth football players. Thirty-six male football players aged 14-16 years were randomly allocated to one of three groups: an SAQ training group, an SSG group, or a control group. The intervention lasted 8 weeks.
Cardiovascular measurements included resting heart rate, systolic blood pressure, diastolic blood pressure, and mean arterial pressure. Assessments were conducted before and after the intervention period. The study investigated whether SAQ training and SSGs produce different cardiovascular adaptations and whether either intervention is superior to regular football training for improving cardiovascular health indicators in youth football players.
This study was conducted in accordance with institutional ethical approval and informed consent procedures.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Qalyubia Governorate
-
Banhā, Qalyubia Governorate, Egypte, 13111
- Benha Sporting Club
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
Accepte les volontaires sains
La description
Inclusion Criteria:
Male football players aged 14 to 16 years. Minimum of 2 years of organized football training experience. Regular participation in football training at least 3 times per week. Ability to participate in all training sessions and assessments. Written informed consent provided by participants and their parents or legal guardians.
Exclusion Criteria:
Musculoskeletal injury within the previous 3 months. History of cardiovascular disease. Metabolic disorders. Neurological disorders. Use of medications that could affect cardiovascular responses or physical performance.
Failure to complete the intervention or assessment procedures.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: SAQ Training Group
Participants received the SAQ training intervention for 8 weeks
|
Participants completed an 8-week Speed, Agility, and Quickness (SAQ) training program designed to improve movement efficiency, agility, acceleration, and cardiovascular adaptations.
Training sessions were integrated into the regular football training schedule and were performed throughout the intervention period
|
|
Expérimental: Small-Sided Games Group
Participants received the Small-Sided Games training intervention for 8 weeks
|
Participants completed an 8-week Small-Sided Games (SSG) training program involving soccer-specific game-based exercises performed in reduced playing areas.
The intervention was designed to provide technical, tactical, and physiological training stimuli and to promote cardiovascular adaptations.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Resting Heart Rate
Délai: Baseline and Week 8
|
Resting heart rate measured in beats per minute (bpm)
|
Baseline and Week 8
|
|
Exercise Heart Rate
Délai: Baseline and Week 8
|
Heart rate measured immediately after completion of the 20-meter shuttle run test.
|
Baseline and Week 8
|
|
Resting Diastolic Blood Pressure
Délai: Baseline and Week 8
|
Resting diastolic blood pressure measured in mmHg.
|
Baseline and Week 8
|
|
Resting Systolic Blood Pressure
Délai: Baseline and Week 8
|
Resting systolic blood pressure measured in mmHg.
|
Baseline and Week 8
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- REF:3/26
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .